CD245 Antikörper
-
- Target
- CD245
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Verwendungszweck
- Anti-Human CD245/MYO18A Antibody (DY12)
- Aufreinigung
- Protein A or G purified.
- Reinheit
- >95 %
- Klon
- DY12
- Isotyp
- IgG1, kappa
-
anti-CD245 antibody
Reaktivität: Human FACS, IHC, IP, WB Wirt: Maus Monoclonal DY12 unconjugated
anti-CD245 antibody (PE)Reaktivität: Human FACS Wirt: Maus Monoclonal DY12 PE
anti-CD245 antibody (PE)Reaktivität: Human FACS, IHC Wirt: Maus Monoclonal DY12 PE
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
- Target
- CD245
- Hintergrund
- CD245, Myosin containing a PDZ domain, MAJN, SP-R210, Surfactant protein receptor SP-R210, MYO18A, MYSPDZ, Unconventional myosin-XVIIIa, KIAA0216, Molecule associated with JAK3 N-terminus
-
